Alkem Lab Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Jun-2023	Mar-2023	Dec-2022	Sep-2022	Jun-2022
Gross Sales	2967.72	2902.60	3040.91	3079.37	2576.38
Excise Duty	--	--	--	--	--
Net Sales	2967.72	2902.60	3040.91	3079.37	2576.38
Other Operating Income	--	--	--	--	--
Other Income	65.84	68.67	45.33	50.67	51.41
Total Income	3033.56	2971.27	3086.24	3130.04	2627.79
Total Expenditure	2578.53	2652.33	2441.86	2625.46	2373.14
PBIDT	455.03	318.94	644.38	504.58	254.65
Interest	29.77	28.96	27.05	24.85	26.50
PBDT	425.26	289.98	617.33	479.73	228.15
Depreciation	72.41	78.32	78.44	77.40	76.26
Minority Interest Before NP	--	--	--	--	--
Tax	65.78	62.86	89.14	86.98	34.92
Deferred Tax	(0.74)	81.12	(10.21)	(32.37)	(14.48)
Reported Profit After Tax	287.81	67.68	459.96	347.72	131.45
Minority Interest After NP	1.08	(3.30)	5.25	16.88	3.81
Net Profit after Minority Interest	286.73	70.98	454.71	330.84	127.64
Extra-ordinary Items	--	(32.93)	--	--	--
Adjusted Profit After Extra-ordinary item	286.73	103.91	454.71	330.84	127.64
EPS (Unit Curr.)	23.98	5.94	38.03	27.67	10.68
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	2,000	--	--
Equity	23.91	23.91	23.91	23.91	23.91
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	15.33	10.99	21.19	16.39	9.88
PBDTM(%)	14.33	9.99	20.30	15.58	8.86
PATM(%)	9.70	2.33	15.13	11.29	5.10

QuickLinks for Alkem Laboratories Ltd.